Treatment for uterine fibroids: Searching for effective drug therapies
Authors:
- 1 March 2012
- journal article
- review article
- Published by Elsevier in Drug Discovery Today: Therapeutic Strategies
- Vol. 9 (1) , e41-e49
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- The estimated annual cost of uterine leiomyomata in the United StatesAmerican Journal of Obstetrics and Gynecology, 2012
- Characterization of tissue biomechanics and mechanical signaling in uterine leiomyomaMatrix Biology, 2012
- Comparing focused ultrasound and uterine artery embolization for uterine fibroids—rationale and design of the Fibroid Interventions: Reducing Symptoms Today and Tomorrow (FIRSTT) trialFertility and Sterility, 2011
- Temperature-Responsive Biocompatible Copolymers Incorporating Hyperbranched Polyglycerols for Adjustable FunctionalityJournal of Functional Biomaterials, 2011
- Effect of the Gonadotropin-Releasing Hormone Analogue Triptorelin on the Occurrence of Chemotherapy-Induced Early Menopause in Premenopausal Women With Breast CancerJAMA, 2011
- A randomized controlled study comparing pain experience between a newly designed needle with a thin tip and a standard needle for oocyte aspirationHuman Reproduction, 2011
- The selective progesterone receptor modulator CDB4124 inhibits proliferation and induces apoptosis in uterine leiomyoma cellsFertility and Sterility, 2010
- Multimodal Regulation of E2F1 Gene Expression by ProgestinsMolecular and Cellular Biology, 2010
- The antifibrotic drug halofuginone inhibits proliferation and collagen production by human leiomyoma and myometrial smooth muscle cellsFertility and Sterility, 2009
- Growth of uterine leiomyomata among premenopausal black and white womenProceedings of the National Academy of Sciences, 2008